These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 12762886)

  • 1. The neurosurgeon as local oncologist: cellular and molecular neurosurgery in malignant glioma therapy.
    Dunn IF; Black PM
    Neurosurgery; 2003 Jun; 52(6):1411-22; discussion 1422-4. PubMed ID: 12762886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current status of local therapy in malignant gliomas--a clinical review of three selected approaches.
    Juratli TA; Schackert G; Krex D
    Pharmacol Ther; 2013 Sep; 139(3):341-58. PubMed ID: 23694764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel therapies for malignant gliomas: a local affair?
    Rainov NG; Söling A; Heidecke V
    Neurosurg Focus; 2006 Apr; 20(4):E9. PubMed ID: 16709040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Input of molecular analysis in medical management of primary brain tumor patients.
    Idbaih A; Duran-Peña A; Bonnet C; Ducray F
    Rev Neurol (Paris); 2015; 171(6-7):457-65. PubMed ID: 26026669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perspectives of cellular and molecular neurosurgery.
    Westphal M; Black PM
    J Neurooncol; 2004 Nov; 70(2):255-69. PubMed ID: 15674483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical evaluation of convection-enhanced delivery of liposomal doxorubicin to treat pediatric diffuse intrinsic pontine glioma and thalamic high-grade glioma.
    Sewing ACP; Lagerweij T; van Vuurden DG; Meel MH; Veringa SJE; Carcaboso AM; Gaillard PJ; Peter Vandertop W; Wesseling P; Noske D; Kaspers GJL; Hulleman E
    J Neurosurg Pediatr; 2017 May; 19(5):518-530. PubMed ID: 28291423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paediatric high and low grade glioma: the impact of tumour biology on current and future therapy.
    Hargrave D
    Br J Neurosurg; 2009 Aug; 23(4):351-63. PubMed ID: 19637006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pediatric Gliomas: Current Concepts on Diagnosis, Biology, and Clinical Management.
    Sturm D; Pfister SM; Jones DTW
    J Clin Oncol; 2017 Jul; 35(21):2370-2377. PubMed ID: 28640698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost of migration: invasion of malignant gliomas and implications for treatment.
    Giese A; Bjerkvig R; Berens ME; Westphal M
    J Clin Oncol; 2003 Apr; 21(8):1624-36. PubMed ID: 12697889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delivery of local therapeutics to the brain: working toward advancing treatment for malignant gliomas.
    Chaichana KL; Pinheiro L; Brem H
    Ther Deliv; 2015 Mar; 6(3):353-69. PubMed ID: 25853310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunobiology and immunotherapeutic targeting of glioma stem cells.
    Madany M; Thomas TM; Edwards L; Yu JS
    Adv Exp Med Biol; 2015; 853():139-66. PubMed ID: 25895711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotherapy for glioma: Current management and future application.
    Xu S; Tang L; Li X; Fan F; Liu Z
    Cancer Lett; 2020 Apr; 476():1-12. PubMed ID: 32044356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Locoregional therapies for glioma.
    Mamelak AN
    Oncology (Williston Park); 2005 Dec; 19(14):1803-10; discussion 1810, 1816-7, 1821-2. PubMed ID: 16506634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endovascular therapies for malignant gliomas: Challenges and the future.
    Su YS; Ali R; Feroze AH; Li G; Lawton MT; Choudhri O
    J Clin Neurosci; 2016 Apr; 26():26-32. PubMed ID: 26857294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changing boundaries in the treatment of malignant gliomas.
    Brandes AA; Basso U; Pasetto LM
    Expert Rev Anticancer Ther; 2001 Oct; 1(3):357-70. PubMed ID: 12113103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel chemotherapeutics and other therapies for treating high-grade glioma.
    Kang JH; Adamson C
    Expert Opin Investig Drugs; 2015; 24(10):1361-79. PubMed ID: 26289791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current status and potential challenges of mesenchymal stem cell-based therapy for malignant gliomas.
    Zhang Q; Xiang W; Yi DY; Xue BZ; Wen WW; Abdelmaksoud A; Xiong NX; Jiang XB; Zhao HY; Fu P
    Stem Cell Res Ther; 2018 Aug; 9(1):228. PubMed ID: 30143053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in the role of toll-like receptors and TLR agonists in immunotherapy for human glioma.
    Deng S; Zhu S; Qiao Y; Liu YJ; Chen W; Zhao G; Chen J
    Protein Cell; 2014 Dec; 5(12):899-911. PubMed ID: 25411122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravascular delivery of neural stem cell lines to target intracranial and extracranial tumors of neural and non-neural origin.
    Brown AB; Yang W; Schmidt NO; Carroll R; Leishear KK; Rainov NG; Black PM; Breakefield XO; Aboody KS
    Hum Gene Ther; 2003 Dec; 14(18):1777-85. PubMed ID: 14670128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Perspectives on postgenome medicine: Gene therapy for brain tumors].
    Mizuno M; Yoshida J
    Nihon Rinsho; 2001 Jan; 59(1):76-80. PubMed ID: 11197866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.